ArticleOncotarget2015

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration.

Xingchen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.